What is DistillerSR?
DistillerSR provides a sophisticated software solution designed to automate the management and analysis of evidence-based research literature. Its platform enables leading healthcare research organizations to conduct literature reviews more efficiently, accurately, and transparently at scale. By streamlining the process of gathering and analyzing data from scientific discoveries, new devices, drugs, and policy guidelines, DistillerSR empowers organizations to accelerate their research workflows and ensure the integrity of their findings.
How much funding has DistillerSR raised?
DistillerSR has raised a total of $20M across 1 funding round:
Other Financing Round
$20M
Other Financing Round (2022): $20M with participation from Thomvest Ventures, Export Development Canada, and Pender Ventures
Key Investors in DistillerSR
Thomvest Ventures
Thomvest Ventures is a venture capital firm known for investing in technology and financial services companies, likely focusing on scalable solutions.
Export Development Canada
Export Development Canada is a Crown corporation that supports and develops Canada's export trade, suggesting an interest in companies with global market potential.
Pender Ventures
Pender Ventures is an investment firm that typically backs technology companies, likely with an interest in innovative software solutions like DistillerSR.
What's next for DistillerSR?
With the backing of $20M in enterprise-level capital, DistillerSR is poised to expand its market reach and enhance its technological capabilities. The recent strategic investment signals a strong belief in the company's trajectory and its potential to become a dominant force in research automation. Future developments are likely to focus on further integrating AI-driven insights and broadening the platform's applicability across diverse scientific and regulatory domains, solidifying its role in advancing evidence-based decision-making globally.
See full DistillerSR company page
